WEX Inc
WEX
169.96
-1.52
-0.89%
WEX Inc
US · WEX
#1968 by market cap
Listed 1970
169.96
-1.52
-0.89%
Live - 5344 symbols - heartbeat 449s ago
· 2026-10-07 19:54
After-hours
169.96
0.00%
- Market cap
- 5.79B
- P/E (TTM)i
- 16.96
- P/Bi
- 4.31
- EPSi
- 8.47
- Div yieldi
- 0.00%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on WEX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.87, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.24% YoY
Margins
- Gross margin
- 58.64%
- Operating margin
- 24.95%
- Net margin
- 11.43%
Key ratios & quality
- Enterprise valuei
- 5.41B
- PEG ratioi
- 1.15
- Altman Z-Scorei
- 0.87
PEG uses trailing P/E against the 3-year net income growth rate (14.72%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.49B | 1.72B | 1.56B | 1.85B | 2.35B | 2.55B | 2.63B | 2.66B |
| Gross profit | 944.71M | 1.06B | 886.69M | 1.15B | 1.42B | 1.57B | 1.59B | 1.56B |
| Selling & admin expenses | 438.55M | 535.68M | 558.79M | 646.00M | 655.70M | 755.80M | 716.80M | 717.20M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 386.29M | 385.84M | 170.57M | 341.90M | 606.40M | 647.10M | 686.40M | 664.00M |
| Pretax profit | 238.62M | 216.52M | -301.08M | 203.90M | 260.50M | 368.80M | 417.80M | 420.20M |
| Tax | 68.84M | 61.22M | -20.60M | 67.80M | 93.10M | 102.20M | 108.20M | 116.10M |
| Net profit | 169.78M | 155.29M | -280.48M | 136.10M | 167.50M | 266.60M | 309.60M | 304.10M |
| Basic EPS | 4 | 2 | -6 | 0 | 5 | 6 | 8 | 9 |
| Diluted EPS | 3.86 | 2.26 | -5.56 | 0.00 | 4.50 | 6.16 | 7.50 | 8.47 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 636.60M | 659.60M | 691.80M | 672.90M | 673.80M | 753.50M |
| Gross profit | 366.60M | 386.80M | 417.40M | 389.20M | 393.70M | 463.80M |
| Selling & admin expenses | 164.60M | 184.00M | 189.30M | 179.40M | 191.90M | 217.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 157.30M | 156.80M | 183.40M | 166.30M | 158.10M | 203.10M |
| Pretax profit | 100.40M | 93.40M | 116.40M | 110.00M | 108.50M | 150.50M |
| Tax | 28.90M | 25.20M | 36.20M | 25.80M | 30.80M | 41.90M |
| Net profit | 71.50M | 68.10M | 80.30M | 84.30M | 77.70M | 108.50M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 1.81 | 1.98 | 2.30 | 2.41 | 2.22 | 3.11 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.40B | 3.84B | 3.50B | 5.30B | 6.82B | 8.94B | 8.52B | 9.71B |
| Cash & ST investments | 541.50M | 810.93M | 852.03M | 1.54B | 2.32B | 4.00B | 4.36B | 5.24B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 6.77B | 8.30B | 8.18B | 10.31B | 11.53B | 13.88B | 13.32B | 14.40B |
| Total current liabilities | 2.31B | 3.05B | 2.74B | 4.40B | 6.29B | 8.52B | 8.33B | 9.29B |
| Short-term debt | 216.52M | 248.53M | 152.73M | 155.77M | 202.60M | 1.04B | 1.29B | 1.33B |
| Long-term debt | 2.13B | 2.69B | 2.87B | 2.70B | 2.52B | 2.83B | 3.08B | 3.53B |
| Total liabilities | 4,974,671,000.00 | 6,205,017,000.00 | 6,148,225,000.00 | 8,213,949,000.00 | 9,879,700,000.00 | 12,061,500,000.00 | 11,832,800,000.00 | 13,165,000,000.00 |
| Total equity | 1.80B | 2.09B | 2.04B | 2.09B | 1.65B | 1.82B | 1.49B | 1.23B |
| Retained earnings | 1.48B | 1.54B | 1.29B | 1.29B | 1.49B | 1.76B | 2.07B | 2.37B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.17B | 9.90B | 9.72B | 9.71B | 10.71B | 11.81B |
| Cash & ST investments | 4.44B | 4.91B | 4.94B | 5.24B | 3.52B | 6.10B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 13.96B | 14.67B | 14.43B | 14.40B | 15.43B | 16.50B |
| Total current liabilities | 8.76B | 9.50B | 9.25B | 9.29B | 10.22B | 11.30B |
| Short-term debt | 1.49B | 1.53B | 1.31B | 1.33B | 1.63B | 1.83B |
| Long-term debt | 4.10B | 3.91B | 3.72B | 3.53B | 3.61B | 3.52B |
| Total liabilities | 13,154,000,000.00 | 13,694,800,000.00 | 13,314,900,000.00 | 13,165,000,000.00 | 14,150,900,000.00 | 15,154,200,000.00 |
| Total equity | 810.40M | 978.70M | 1.12B | 1.23B | 1.27B | 1.34B |
| Retained earnings | 2.14B | 2.21B | 2.29B | 2.37B | 2.45B | 2.56B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 400.23M | 663.17M | 736.80M | -42.60M | 679.40M | 907.90M | 481.40M | 454.30M |
| Depreciation & amortization | 199.81M | 237.13M | 261.93M | 272.60M | 263.90M | 276.20M | 321.30M | 331.10M |
| Free cash flow | 313.08M | 560.31M | 656.33M | -128.60M | 563.20M | 759.80M | 329.00M | 240.60M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 90.00M | 0 | -282.80M | -303.40M | -652.00M | -799.80M |
| Ending cash balance | 555.03M | 981.38M | 1.33B | 1.26B | 1.86B | 2.23B | 1.44B | 1.68B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -481.60M | 264.60M | 376.60M | 294.70M | -330.80M | -77.60M |
| Depreciation & amortization | 81.50M | 84.00M | 83.70M | 81.90M | 81.60M | 83.00M |
| Free cash flow | -528.70M | 230.00M | 341.60M | 197.70M | -368.30M | -121.10M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -790.00M | -9.70M | -100.00K | 0 | 0 | -63.80M |
| Ending cash balance | 1.28B | 1.53B | 1.48B | 1.68B | 1.24B | 1.77B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.63 | 5.33 | -12.72 | 0.01 | 11.55 | 15.37 | 18.71 | 22.33 |
| ROA %i | 2.49 | 1.31 | -2.96 | 0.00 | 1.85 | 2.10 | 2.28 | 2.19 |
| ROIC %i | 5.72 | 4.35 | -1.99 | 1.79 | 6.30 | 8.24 | 8.39 | 8.00 |
| 5-year avg ROE %i | 10.42 | 7.36 | 2.92 | 2.55 | 2.81 | 3.91 | 6.58 | 13.59 |
| EBIT margin %i | 23.02 | 20.37 | -9.23 | 17.96 | 16.64 | 22.50 | 24.87 | 24.83 |
| FCF / sales %i | 20.97 | 32.51 | 49.78 | 3.48 | 23.96 | 29.82 | 12.52 | 9.04 |
| Current ratioi | 1.47 | 1.26 | 1.28 | 1.20 | 1.08 | 1.05 | 1.02 | 1.05 |
| Quick ratioi | 1.35 | 1.14 | 1.04 | 1.01 | 0.89 | 0.87 | 0.88 | 0.93 |
| Debt / assetsi | 34.72 | 35.37 | 36.99 | 27.66 | 23.63 | 27.87 | 32.84 | 33.74 |
| LT debt / equityi | 119.50 | 139.42 | 150.88 | 146.59 | 152.91 | 155.31 | 207.02 | 286.11 |
| Interest coveragei | 3.27 | 2.61 | -0.92 | 2.59 | 2.99 | 2.80 | 2.77 | 2.75 |
| Revenue CAGR (3Y) %i | 20.43 | 19.41 | 7.70 | 7.43 | 10.89 | 17.77 | 12.40 | 4.22 |
| Net income CAGR (3Y) %i | 18.20 | 61.51 | -- | -91.59 | 26.71 | -- | 1,357.47 | 14.72 |
| FCF CAGR (3Y) %i | -6.39 | -- | 126.95 | -- | 0.17 | 5.00 | -- | -24.69 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 24.37 | 22.19 | 20.29 | 22.33 | 29.77 | 30.19 |
| ROA %i | 2.22 | 2.12 | 2.00 | 2.19 | 2.11 | 2.25 |
| ROIC %i | 7.82 | 7.72 | 7.38 | 8.00 | 7.52 | 7.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.14 | 24.98 | 24.00 | 24.83 | 24.81 | 25.57 |
| FCF / sales %i | -- | 10.36 | 24.48 | 9.04 | 14.86 | 1.79 |
| Current ratioi | 1.05 | 1.04 | 1.05 | 1.05 | 1.05 | 1.04 |
| Quick ratioi | 0.94 | 0.93 | 0.95 | 0.93 | 0.77 | 0.96 |
| Debt / assetsi | 39.99 | 37.08 | 34.82 | 33.74 | 33.95 | 32.47 |
| LT debt / equityi | 505.86 | 399.42 | 332.54 | 286.11 | 282.93 | 262.01 |
| Interest coveragei | 2.87 | 2.78 | 2.63 | 2.75 | 2.78 | 3.13 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Mobility is the largest reported line at 56.06% of revenue, across 3 reported segments.
- Benefits follows at 27.34%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Mobility56.06%
Benefits27.34%
Corporate payments16.60%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.